MEDIFAST Other Current Assets vs Non Current Assets Total Analysis
MED Stock | USD 25.93 0.43 1.63% |
MEDIFAST INC financial indicator trend analysis is infinitely more than just investigating MEDIFAST INC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MEDIFAST INC is a good investment. Please check the relationship between MEDIFAST INC Other Current Assets and its Non Current Assets Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
Other Current Assets vs Non Current Assets Total
Other Current Assets vs Non Current Assets Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MEDIFAST INC Other Current Assets account and Non Current Assets Total. At this time, the significance of the direction appears to have strong relationship.
The correlation between MEDIFAST INC's Other Current Assets and Non Current Assets Total is 0.7. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of MEDIFAST INC, assuming nothing else is changed. The correlation between historical values of MEDIFAST INC's Other Current Assets and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of MEDIFAST INC are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Other Current Assets i.e., MEDIFAST INC's Other Current Assets and Non Current Assets Total go up and down completely randomly.
Correlation Coefficient | 0.7 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Most indicators from MEDIFAST INC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MEDIFAST INC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.At present, MEDIFAST INC's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 417.1 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.48.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.1B | 1.1B | 775.9M | 814.6M | Total Revenue | 1.5B | 1.6B | 1.1B | 1.1B |
MEDIFAST INC fundamental ratios Correlations
Click cells to compare fundamentals
MEDIFAST INC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MEDIFAST INC fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 194.7M | 276.1M | 398.3M | 316.2M | 309.9M | 325.4M | |
Other Current Liab | 49.3M | 64.3M | 84.4M | 69.1M | 46.6M | 49.0M | |
Total Current Liabilities | 79.4M | 111.4M | 169.8M | 140.9M | 92.3M | 96.9M | |
Total Stockholder Equity | 104.8M | 157.2M | 202.5M | 155.0M | 201.5M | 211.6M | |
Property Plant And Equipment Net | 38.8M | 38.1M | 80.6M | 75.6M | 67.1M | 70.5M | |
Net Debt | (63.4M) | (152.6M) | (71.6M) | (61.6M) | (72.4M) | (68.8M) | |
Retained Earnings | 168.8M | 154.4M | 190.3M | 139.9M | 174.6M | 183.4M | |
Cash | 77.0M | 163.7M | 104.2M | 87.7M | 94.4M | 99.2M | |
Non Current Assets Total | 40.5M | 41.8M | 91.5M | 93.4M | 85.9M | 90.2M | |
Non Currrent Assets Other | 353K | 2.9M | 6.5M | 12.5M | 14.7M | 15.4M | |
Cash And Short Term Investments | 92.7M | 174.5M | 109.5M | 87.7M | 150.0M | 157.5M | |
Net Receivables | 1.0M | 1.4M | 584K | 1.0 | 8.7M | 9.2M | |
Common Stock Shares Outstanding | 12.1M | 11.9M | 11.8M | 11.3M | 10.9M | 12.2M | |
Liabilities And Stockholders Equity | 194.7M | 276.1M | 398.3M | 316.2M | 309.9M | 325.4M | |
Non Current Liabilities Total | 10.4M | 7.5M | 26.0M | 20.3M | 16.1M | 16.9M | |
Inventory | 48.8M | 53.4M | 180.0M | 118.9M | 54.6M | 27.8M | |
Other Current Assets | 11.3M | 5.9M | 17.3M | 16.2M | 10.7M | 5.5M | |
Other Stockholder Equity | (64.0M) | 2.8M | 12.0M | 15.2M | 26.6M | 27.9M | |
Total Liab | 89.8M | 118.8M | 195.9M | 161.2M | 108.4M | 113.8M | |
Property Plant And Equipment Gross | 38.8M | 38.1M | 113.3M | 115.6M | 114.4M | 120.1M | |
Total Current Assets | 154.2M | 234.3M | 306.9M | 222.8M | 224.0M | 235.2M | |
Short Term Debt | 3.2M | 3.7M | 6.5M | 5.8M | 5.9M | 6.2M | |
Accounts Payable | 22.6M | 35.8M | 70.9M | 58.7M | 39.2M | 21.4M | |
Accumulated Other Comprehensive Income | 25K | 41K | 111K | 24K | 248K | 260.4K | |
Other Assets | 1.7M | 14.1M | 10.9M | 17.8M | 20.5M | 21.5M | |
Short Term Investments | 15.7M | 10.8M | 5.4M | (23K) | 55.6M | 58.4M | |
Property Plant Equipment | 26.0M | 27.6M | 56.1M | 57.2M | 65.8M | 69.1M | |
Net Tangible Assets | 104.8M | 157.2M | 202.5M | 155.0M | 178.3M | 125.0M | |
Retained Earnings Total Equity | 168.8M | 154.4M | 190.3M | 139.9M | 160.8M | 126.9M | |
Capital Surpluse | 0.0 | 7.8M | 12.0M | 21.6M | 19.4M | 10.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
CEOs Directory Screen CEOs from public companies around the world | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.79) | Dividend Share 3.3 | Earnings Share 9.1 | Revenue Per Share 82.404 | Quarterly Revenue Growth (0.50) |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.